Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger issue of high drug costs ...

I learned that Americans spent $35.5 billion (and rising) on asthma conditions alone. One reason for the increase in medication prices, as well as asthma diagnoses, is climate change. I stood in shock ...

Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Utah said that with its new AI prescription drug chatbot, it wants to free up doctors to focus on patient care and make ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...